Industry NewsDako Announces Collaboration on Development of PD-L1 Companion Diagnostic Test for Investigational Cancer Drug Opdivo® (nivolumab)
Product NewsFDA Approves Two Dako Assays as Companion Diagnostics for Genentech’s New Breast Cancer Medicine Kadcyla
